购物车
- 全部删除
- 您的购物车当前为空
Azelaoyl PAF是一种强效的PPARγ激动剂,能够竞争性地结合噻唑烷二酮类药物,与罗格列酮(rosiglitazone)的效力相当。在动脉粥样硬化研究中,Azelaoyl PAF通过上调CD36的表达,促进巨噬细胞对氧化低密度脂蛋白(oxLDL)的摄取。在Friedreich's ataxia(FRDA)患者的成纤维细胞中,Azelaoyl PAF显著提高了铁蛋白的mRNA和蛋白质水平。
Azelaoyl PAF是一种强效的PPARγ激动剂,能够竞争性地结合噻唑烷二酮类药物,与罗格列酮(rosiglitazone)的效力相当。在动脉粥样硬化研究中,Azelaoyl PAF通过上调CD36的表达,促进巨噬细胞对氧化低密度脂蛋白(oxLDL)的摄取。在Friedreich's ataxia(FRDA)患者的成纤维细胞中,Azelaoyl PAF显著提高了铁蛋白的mRNA和蛋白质水平。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
500 μg | 询价 | 35日内发货 | |
1 mg | 询价 | 35日内发货 | |
5 mg | 询价 | 35日内发货 | |
10 mg | 询价 | 35日内发货 |
产品描述 | Azelaoyl PAF is a potent PPARγ agonist that competitively binds thiazolidinediones with potency comparable to rosiglitazone. In atherosclerosis studies, Azelaoyl PAF promotes the uptake of oxidized low-density lipoprotein (oxLDL) by macrophages by upregulating CD36 expression. In fibroblasts from Friedreich's ataxia (FRDA) patients, Azelaoyl PAF significantly increased mRNA and protein levels of ferritin. |
别名 | 1-Hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine |
分子量 | 651.85 |
分子式 | C33H66NO9P |
CAS No. | 354583-69-0 |
Smiles | [C@@H](COP(OCC[N+](C)(C)C)(=O)[O-])(OC(CCCCCCCC(O)=O)=O)COCCCCCCCCCCCCCCCC |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | Ethanol: 10.00 mg/mL (15.34 mM), Sonication is recommended. PBS (pH 7.2): 6.00 mg/mL (9.20 mM), Sonication is recommended. DMSO: 6.00 mg/mL (9.20 mM), Sonication is recommended. DMF: 20.00 mg/mL (30.68 mM), Sonication is recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
PBS (pH 7.2)/DMSO/Ethanol/DMF
|
评论内容